Scientific Advisory Committee

The Fisher Drug Discovery Resource Center is advised by Rockefeller University investigators whose expertise spans chemical biology, drug discovery, structural biology, biophysics, and translational medicine.

The committee provides scientific perspective on the Center’s capabilities, emerging technologies, and research priorities, helping the DDRC evaluate new capabilities and respond to emerging opportunities in early-stage drug discovery.

Committee Members

Thomas Tuschl, Ph.D. — Chair
F. M. Al Akl, M.D. and Margaret Al Akl Professor
RNA biology, chemical biology, innate immunity, and therapeutic discovery

Sean F. Brady, Ph.D.
Evnin Professor
Natural products, chemical biology, and small-molecule discovery

Jue Chen, Ph.D.
William E. Ford Professor; Investigator, Howard Hughes Medical Institute
Membrane protein structure, function, and biophysics

Barry S. Coller, M.D.
David Rockefeller Professor; Physician in Chief, Emeritus
Platelet biology, thrombosis, and translational therapeutics